Stock Scorer
FBT

First Trust NYSE Arca Biotechnology Index Fund

1 year +44.9%

Every component of FBT and its weight in the fund, as of 2026-10-22.

ComponentWeight%Sector
HALOHalozyme Therapeutics Inc · United States 3.85% Healthcare
ALKSAlkermes Plc · United States 3.66% Healthcare
BGNEBeiGene Ltd · United States 3.63% Healthcare
EXELExelixis Inc · United States 3.57% Healthcare
REGNRegeneron Pharmaceuticals Inc · United States 3.52% Healthcare
BIIBBiogen Inc · United States 3.45% Healthcare
RGENRepligen Corporation · United States 3.45% Healthcare
INCYIncyte Corporation · United States 3.38% Healthcare
ADMAADMA Biologics Inc · United States 3.37% Healthcare
VRTXVertex Pharmaceuticals Inc · United States 3.37% Healthcare
VCYTVeracyte Inc · United States 3.36% Healthcare
NTRANatera Inc · United States 3.35% Healthcare
TGTXTG Therapeutics Inc · United States 3.34% Healthcare
BMRNBiomarin Pharmaceutical Inc · United States 3.34% Healthcare
AMGNAmgen Inc · United States 3.31% Healthcare
TARSTarsus Pharmaceuticals Inc · United States 3.29% Healthcare
ARGXargenx NV ADR · United States 3.29% Healthcare
GMABGenmab AS · United States 3.28% Healthcare
NBIXNeurocrine Biosciences Inc · United States 3.26% Healthcare
TECHBio-Techne Corp · United States 3.24% Healthcare
NEONeoGenomics Inc · United States 3.23% Healthcare
GILDGilead Sciences Inc · United States 3.22% Healthcare
BNTXBioNTech SE · United States 3.21% Healthcare
BRKRBruker Corporation · United States 3.18% Healthcare
UTHRUnited Therapeutics Corporation · United States 3.17% Healthcare
AXSMAxsome Therapeutics Inc · United States 3.13% Healthcare
ALNYAlnylam Pharmaceuticals Inc · United States 3.10% Healthcare
MDGLMadrigal Pharmaceuticals Inc · United States 3.10% Healthcare
ILMNIllumina Inc · United States 3.07% Healthcare
CORTCorcept Therapeutics Incorporated · United States 3.06% Healthcare

From the market data provider's fund data, read 2026-10-22. Returns are the fund's own; past returns say nothing certain about future ones. None of this is advice.